Skip to content
10-K

Annual Report

BioPlus Acquisition Corp.

0001193125-22-073378

← back to feed
Filed
Mar 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Cash And Equivalents FY 2021 · Dec 31, 2021 $635.54K
Cash And Equivalents FY 2021 · Feb 10, 2021 $0